AI Is Rewriting
Medicine Itself

$3B+ Est. Valuation  ·  $3B+ Pharma Deals  ·  DeepMind Spinout

AlphaFold commercialized. Eli Lilly and Novartis paid $3B+ in partnership deals before a single drug reaches a trial. Full drug discovery AI market model and standalone IPO thesis. 18 pages.

1M+ Physicians Monthly  ·  $6B+ Est. Val.  ·  Mayo Clinic Partner

The AI replacing PubMed and UpToDate for every physician on earth. Real-time synthesis of peer-reviewed medical literature, 1M+ monthly physician users, and the full commercial thesis on the most important clinical AI tool in medicine.

$1.64B Valuation  ·  $278M Raised  ·  AI Health Agent

The AI healthcare agent designed to address the global shortage of healthcare workers. Chronic care management, patient navigation, and post-discharge follow-up at a fraction of the cost of human staff. The full commercial model and 2026 growth thesis.

$8.5B Valuation  ·  $650M Raised  ·  FDA Breakthrough Device

First human trials complete. N1 chip implanted in three patients, enabling full computer control via thought. FDA Breakthrough Device designation, the full neurotechnology commercialization timeline, and the long-horizon thesis for brain-computer interfaces in medicine.

$850M Valuation  ·  UPMC & Epic Deployed  ·  $212M Raised

AI that listens to every doctor-patient conversation and writes the clinical note automatically. UPMC and Epic integrations, 250+ health system deployments, and the full ambient clinical documentation market — one of the fastest-growing enterprise health AI companies in the world.

$1B+ Valuation  ·  $100M Raised  ·  Ambient AI Scribe

Competing with Abridge in the ambient clinical documentation space. Multispecialty AI scribe platform, $100M Series B, and the full competitive analysis of who wins the race to eliminate physician administrative burden. 15 pages.

$320M Raised  ·  Prior Authorization AI  ·  Payer Deployed

Prior authorization kills patients. Anterior's AI processes prior auth requests in seconds instead of days, reducing denials and saving lives. Full payer and provider deployment model, $320M raised, and the prior authorization AI market thesis.

$45M Raised  ·  European Clinical AI Leader  ·  30+ Specialties

Paris-based ambient AI platform for clinical documentation across 30+ medical specialties. The European clinical AI thesis and how Nabla is positioning itself as the non-US alternative to Abridge and Ambience as European healthcare systems deploy AI at scale.

$165M Raised  ·  10K+ Physicians  ·  Epic Integration

Voice AI assistant for physicians — turning spoken clinical observations into structured EHR documentation. 10,000+ physician users, Epic integration, and the full voice-driven clinical workflow market that sits alongside ambient documentation.

AI Materials Science  ·  Drug Discovery Applications  ·  Founded 2022

AI-driven materials science platform with applications in pharmaceutical development and advanced materials. Full research methodology, commercial pipeline, and the intersection of materials AI and drug discovery that makes Periodic Labs one of the most watched early-stage healthcare AI companies.

$1B Raised  ·  David Baker  ·  AI Drug Design

$1 billion raised on Day 1 for AI-driven protein design and drug discovery, led by Nobel Prize winner David Baker. The full AI drug design thesis, protein engineering market, and why Xaira's approach to designing entirely new proteins may represent the most important shift in pharmaceutical development in a generation.

$30M Raised  ·  Open-Source AlphaFold Alternative  ·  Founded 2024

Chai-1, the open-source competitor to AlphaFold, released in 2024 and immediately matched or exceeded AlphaFold's performance on standard benchmarks. The full open-source drug discovery thesis, $30M raised, and why Chai may commoditize the very breakthrough Isomorphic Labs is trying to commercialize.

Nobel Prize 2024  ·  200M+ Structures  ·  Google DeepMind

The Nobel Prize-winning AI system that solved protein structure prediction — one of biology's greatest 50-year unsolved problems — in a single year. 200M+ protein structures in the public database, $0 cost to every researcher on earth, and the full analysis of how AlphaFold is the foundational infrastructure on which every drug discovery AI company is built. 16 pages.